Metraipolis › archive › dc_ecbe7879988f
Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1 — Europe PMC PMID:42056527
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42056527
- DOI
- 10.1038/s41586-[numero omesso]-w
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T02:24:50.655Z
- SHA-256 of the archived text
8eec3a5fa40f66863fc9a42e6d1a8ea0c07386a7d2fbce662f84bc4db544d6f3- Stable URL of this page
https://metraipolis.com/documento/dc_ecbe7879988f
How to cite
Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1 — Europe PMC PMID:42056527 — Europe PMC (en), https://europepmc.org/article/MED/42056527 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ecbe7879988f (Metraipolis archive dc_ecbe7879988f, sha256 8eec3a5fa40f66863fc9a42e6d1a8ea0c07386a7d2fbce662f84bc4db544d6f3)
BibTeX
@misc{dcecbe7879988f,
title = {Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1 — Europe PMC PMID:42056527},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42056527},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ecbe7879988f; sha256 8eec3a5fa40f66863fc9a42e6d1a8ea0c07386a7d2fbce662f84bc4db544d6f3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42056527. Agents can read the archived copy with the MCP tool read_document.